Detalhe da pesquisa
1.
Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial.
Lancet Rheumatol
; 5(1): e14-e23, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38251504